Published in Mol Neurobiol on October 02, 2014
Traumatic Axonal Injury: Mechanisms and Translational Opportunities. Trends Neurosci (2016) 0.80
Dehydroascorbic Acid Attenuates Ischemic Brain Edema and Neurotoxicity in Cerebral Ischemia: An in vivo Study. Exp Neurobiol (2015) 0.79
Leukocyte Calpain Deficiency Reduces Angiotensin II-Induced Inflammation and Atherosclerosis But Not Abdominal Aortic Aneurysms in Mice. Arterioscler Thromb Vasc Biol (2016) 0.78
Dysfunction of the β2-spectrin-based pathway in human heart failure. Am J Physiol Heart Circ Physiol (2016) 0.77
Deciphering glycomics and neuroproteomic alterations in experimental traumatic brain injury: Comparative analysis of aspirin and clopidogrel treatment. Electrophoresis (2016) 0.76
SBDPs and Tau proteins for diagnosis and hypothermia therapy in neonatal hypoxic ischemic encephalopathy. Exp Ther Med (2016) 0.75
Caspase-3/7-mediated Cleavage of β2-spectrin is Required for Acetaminophen-induced Liver Damage. Int J Biol Sci (2016) 0.75
Neuroproteomics and Systems Biology Approach to Identify Temporal Biomarker Changes Post Experimental Traumatic Brain Injury in Rats. Front Neurol (2016) 0.75
The neuroprotective effect of latanoprost acts via klotho-mediated suppression of calpain activation after optic nerve transection. J Neurochem (2016) 0.75
Novel Bioinformatics-Based Approach for Proteomic Biomarkers Prediction of Calpain-2 &Caspase-3 Protease Fragmentation: Application to βII-Spectrin Protein. Sci Rep (2017) 0.75
Crystal structure of a Src-homology 3 (SH3) domain. Nature (1992) 13.88
SH3--an abundant protein domain in search of a function. FEBS Lett (1992) 12.98
Spectrin and ankyrin-based pathways: metazoan inventions for integrating cells into tissues. Physiol Rev (2001) 6.31
Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem (1984) 3.39
Calpain and caspase: can you tell the difference? Trends Neurosci (2000) 3.14
The spectrin-based membrane skeleton and micron-scale organization of the plasma membrane. Annu Rev Cell Biol (1993) 2.62
Axonal damage: a key predictor of outcome in human CNS diseases. Brain (2003) 2.27
Spectrin tethers and mesh in the biosynthetic pathway. J Cell Sci (2000) 2.21
Cell death mechanisms following traumatic brain injury. Brain Pathol (2004) 2.20
Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice. Science (2003) 2.16
White matter damage and cognitive impairment after traumatic brain injury. Brain (2010) 2.11
Non-erythroid alpha-spectrin breakdown by calpain and interleukin 1 beta-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis. Biochem J (1996) 2.05
Traumatically induced axonal injury: pathogenesis and pathobiological implications. Brain Pathol (1992) 2.02
Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J Biol Chem (1996) 1.88
The calpains: modular designs and functional diversity. Genome Biol (2007) 1.80
Calpain activation in apoptosis. J Cell Physiol (1994) 1.72
Simultaneous degradation of alphaII- and betaII-spectrin by caspase 3 (CPP32) in apoptotic cells. J Biol Chem (1998) 1.72
Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo. Neuron (1988) 1.67
A Ca(2+) switch aligns the active site of calpain. Cell (2002) 1.65
Specific cleavage of alpha-fodrin during Fas- and tumor necrosis factor-induced apoptosis is mediated by an interleukin-1beta-converting enzyme/Ced-3 protease distinct from the poly(ADP-ribose) polymerase protease. J Biol Chem (1996) 1.57
A caspase inhibitor, IDN-6556, ameliorates early hepatic injury in an ex vivo rat model of warm and cold ischemia. Liver Transpl (2007) 1.53
Cytochrome c release and caspase activation in traumatic axonal injury. J Neurosci (2000) 1.53
Apoptosis after traumatic brain injury. J Neurotrauma (2000) 1.45
Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons in the ischemic gerbil brain. J Neurosci (1994) 1.45
Mild traumatic brain injury: a risk factor for neurodegeneration. Alzheimers Res Ther (2010) 1.43
Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats. J Neurochem (2001) 1.42
Regional calpain and caspase-3 proteolysis of alpha-spectrin after traumatic brain injury. Neuroreport (1998) 1.39
A panel of neuron-enriched proteins as markers for traumatic brain injury in humans. J Neurotrauma (2009) 1.39
Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C. Hepatology (2007) 1.38
Clinical Trial of the Pan-Caspase Inhibitor, IDN-6556, in Human Liver Preservation Injury. Am J Transplant (2007) 1.36
Binding of PH domains of beta-adrenergic receptor kinase and beta-spectrin to WD40/beta-transducin repeat containing regions of the beta-subunit of trimeric G-proteins. Biochem Biophys Res Commun (1994) 1.35
Nonspecific white matter degeneration following traumatic brain injury. J Int Neuropsychol Soc (1995) 1.32
Novel differential neuroproteomics analysis of traumatic brain injury in rats. Mol Cell Proteomics (2006) 1.28
αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients. J Neurotrauma (2010) 1.26
Quantitative structural changes in white and gray matter 1 year following traumatic brain injury in rats. Acta Neuropathol (2002) 1.23
A novel marker for traumatic brain injury: CSF alphaII-spectrin breakdown product levels. J Neurotrauma (2004) 1.22
Identification of two regions of beta G spectrin that bind to distinct sites in brain membranes. J Biol Chem (1994) 1.20
Accumulation of calpain and caspase-3 proteolytic fragments of brain-derived alphaII-spectrin in cerebral spinal fluid after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab (2004) 1.18
Serum concentrations of ubiquitin C-terminal hydrolase-L1 and αII-spectrin breakdown product 145 kDa correlate with outcome after pediatric TBI. J Neurotrauma (2012) 1.18
Comparing calpain- and caspase-3-mediated degradation patterns in traumatic brain injury by differential proteome analysis. Biochem J (2006) 1.18
Binding of spectrin alpha 2-beta 2 tetramers to human erythrocyte membranes. J Biol Chem (1980) 1.13
Multiple alphaII-spectrin breakdown products distinguish calpain and caspase dominated necrotic and apoptotic cell death pathways. Apoptosis (2009) 1.12
Calpain activity in the rat brain after transient forebrain ischemia. Exp Neurol (2001) 1.12
Calmodulin and calcium-dependent protease I coordinately regulate the interaction of fodrin with actin. Proc Natl Acad Sci U S A (1990) 1.11
alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury. J Neurotrauma (2009) 1.11
Heteronuclear ribonucleoproteins C1 and C2, components of the spliceosome, are specific targets of interleukin 1beta-converting enzyme-like proteases in apoptosis. J Biol Chem (1996) 1.10
Extensive degradation of myelin basic protein isoforms by calpain following traumatic brain injury. J Neurochem (2006) 1.07
The spectrin membrane skeleton: emerging concepts. Curr Opin Cell Biol (1989) 1.05
Mechanisms of calpain proteolysis following traumatic brain injury: implications for pathology and therapy: implications for pathology and therapy: a review and update. J Neurotrauma (1997) 1.05
In vitro proteolysis of brain spectrin by calpain I inhibits association of spectrin with ankyrin-independent membrane binding site(s). J Biol Chem (1991) 1.02
The pathological spectrum of diffuse axonal injury in blunt head trauma: assessment with axon and myelin strains. Clin Neurol Neurosurg (1994) 1.01
Membrane domain organization of myelinated axons requires βII spectrin. J Cell Biol (2013) 1.01
Cell organization, growth, and neural and cardiac development require αII-spectrin. J Cell Sci (2011) 0.99
Sequential degradation of alphaII and betaII spectrin by calpain in glutamate or maitotoxin-stimulated cells. Biochemistry (2007) 0.98
Identification of a novel C-terminal variant of beta II spectrin: two isoforms of beta II spectrin have distinct intracellular locations and activities. J Cell Sci (2000) 0.98
Spectrin proteolysis in the hippocampus: a biochemical marker for neuronal injury and neuroprotection. Ann N Y Acad Sci (1993) 0.98
Ischemia triggers NMDA receptor-linked cytoskeletal proteolysis in hippocampus. Brain Res (1989) 0.97
Ankyrin-B is required for coordinated expression of beta-2-spectrin, the Na/K-ATPase and the Na/Ca exchanger in the inner segment of rod photoreceptors. Exp Eye Res (2008) 0.95
Stimulation of NMDA receptors activates calpain in cultured hippocampal slices. Neurosci Lett (1994) 0.94
Spectrin: on the path from structure to function. Curr Opin Cell Biol (1996) 0.94
beta-Spectrin functions independently of Ankyrin to regulate the establishment and maintenance of axon connections in the Drosophila embryonic CNS. Development (2006) 0.93
Calpain proteolysis of alpha II-spectrin in the normal adult human brain. Neurosci Lett (2001) 0.92
Effects of ICE-like protease and calpain inhibitors on neuronal apoptosis. Neuroreport (1996) 0.91
Neuronal fodrin proteolysis occurs independently of excitatory amino acid-induced neurotoxicity. Neuron (1991) 0.91
Proteolysis of submembrane cytoskeletal proteins ankyrin-G and αII-spectrin following diffuse brain injury: a role in white matter vulnerability at Nodes of Ranvier. Brain Pathol (2010) 0.90
Intrahippocampal colchicine injection results in spectrin proteolysis. Neuroscience (1989) 0.89
Dual vulnerability of tau to calpains and caspase-3 proteolysis under neurotoxic and neurodegenerative conditions. ASN Neuro (2011) 0.89
Exploration of orally available calpain inhibitors: peptidyl alpha-ketoamides containing an amphiphile at P3 site. Bioorg Med Chem (2005) 0.89
Activation of apoptosis-linked caspase(s) in NMDA-injured brains in neonatal rats. Neurochem Int (2000) 0.89
Calpain-induced proteolysis of beta-spectrins. FEBS Lett (1999) 0.86
Heavy neurofilament accumulation and alpha-spectrin degradation accompany cerebellar white matter functional deficits following forebrain fluid percussion injury. Exp Neurol (2006) 0.86
Evidence That the Blood Biomarker SNTF Predicts Brain Imaging Changes and Persistent Cognitive Dysfunction in Mild TBI Patients. Front Neurol (2013) 0.86
Effects of positive AMPA receptor modulators on calpain-mediated spectrin degradation in cultured hippocampal slices. Neurochem Int (2005) 0.84
Cysteine protease inhibitor E64 reduces the rate of formation of selenite cataract in the whole animal. Curr Eye Res (1991) 0.84
Spectrins in developing rat hippocampal cells. Brain Res Dev Brain Res (2001) 0.83
Structural insight into an ankyrin-sensitive lipid-binding site of erythroid beta-spectrin. Mol Membr Biol (2007) 0.80
Extracellular calcium deprivation in astrocytes: regulation of mRNA expression and apoptosis. J Neurochem (1998) 0.79
Inhibition of calpain but not caspase activity by spectrin fragments. Cell Mol Biol Lett (2010) 0.79
The pathophysiology of prospective memory failure after diffuse axonal injury--lesion-symptom analysis using diffusion tensor imaging. BMC Neurosci (2010) 0.79
Clinicopathologic observations in 100 consecutive patients with fatal head injury admitted to a neurosurgical unit. Ir Med J (1995) 0.77
Developmental status of neurons selectively vulnerable to rapidly triggered post-ischemic caspase activation. Neurosci Lett (2004) 0.77
IDN-6556 Idun Pharmaceuticals Inc. Curr Opin Investig Drugs (2004) 0.76
Lesions of entorhinal cortex produce a calpain-mediated degradation of brain spectrin in dentate gyrus. II. Anatomical studies. Brain Res (1988) 0.76
Formation and properties of spectrin containing a truncated beta-chain, generated by an endogenous calcium-dependent protease. J Biol Chem (1991) 0.75
Haemolysis caused by alterations of alpha- and beta-spectrin after 10 to 35 min of severe exercise. Eur J Appl Physiol (2005) 0.75
A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol (2005) 4.95
Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol (2007) 3.08
Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury. Crit Care Med (2010) 2.44
Chronic arsenic exposure and cardiac repolarization abnormalities with QT interval prolongation in a population-based study. Environ Health Perspect (2007) 1.73
Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study. Crit Care (2011) 1.68
Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention. Ann Emerg Med (2011) 1.65
Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury. J Neurotrauma (2007) 1.58
Calpain in the CNS: from synaptic function to neurotoxicity. Sci Signal (2008) 1.52
Morphologic and biochemical characterization of brain injury in a model of controlled blast overpressure exposure. J Trauma (2010) 1.49
Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein. J Neurotrauma (2013) 1.40
Common data elements for traumatic brain injury: recommendations from the biospecimens and biomarkers working group. Arch Phys Med Rehabil (2010) 1.35
Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention. J Trauma Acute Care Surg (2012) 1.34
Polymer genomics: shifting the gene and drug delivery paradigms. J Control Release (2005) 1.31
Occult hepatitis B virus in liver tissue of individuals without hepatic disease. J Hepatol (2008) 1.31
Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids. J Neurotrauma (2011) 1.31
Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats. Eur J Neurosci (2010) 1.28
Novel differential neuroproteomics analysis of traumatic brain injury in rats. Mol Cell Proteomics (2006) 1.28
Calpain-mediated collapsin response mediator protein-1, -2, and -4 proteolysis after neurotoxic and traumatic brain injury. J Neurotrauma (2007) 1.26
αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients. J Neurotrauma (2010) 1.26
Changes in vascular permeability and expression of different angiogenic factors following anti-angiogenic treatment in rat glioma. PLoS One (2010) 1.24
Neuroprotection targets after traumatic brain injury. Curr Opin Neurol (2006) 1.23
The effect of the nonionic block copolymer pluronic P85 on gene expression in mouse muscle and antigen-presenting cells. Biomaterials (2008) 1.19
Accumulation of calpain and caspase-3 proteolytic fragments of brain-derived alphaII-spectrin in cerebral spinal fluid after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab (2004) 1.18
Serum concentrations of ubiquitin C-terminal hydrolase-L1 and αII-spectrin breakdown product 145 kDa correlate with outcome after pediatric TBI. J Neurotrauma (2012) 1.18
Comparing calpain- and caspase-3-mediated degradation patterns in traumatic brain injury by differential proteome analysis. Biochem J (2006) 1.18
Ischemia-reperfusion-induced calpain activation and SERCA2a degradation are attenuated by exercise training and calpain inhibition. Am J Physiol Heart Circ Physiol (2005) 1.17
Calpain and caspase processing of caspase-12 contribute to the ER stress-induced cell death pathway in differentiated PC12 cells. Apoptosis (2010) 1.16
Biomarkers of blast-induced neurotrauma: profiling molecular and cellular mechanisms of blast brain injury. J Neurotrauma (2009) 1.15
Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury. Neurosurgery (2012) 1.14
Proteomic identification of biomarkers of traumatic brain injury. Expert Rev Proteomics (2005) 1.14
Multiple alphaII-spectrin breakdown products distinguish calpain and caspase dominated necrotic and apoptotic cell death pathways. Apoptosis (2009) 1.12
Biochemical, structural, and biomarker evidence for calpain-mediated cytoskeletal change after diffuse brain injury uncomplicated by contusion. J Neuropathol Exp Neurol (2009) 1.12
Calpain mediates pulmonary vascular remodeling in rodent models of pulmonary hypertension, and its inhibition attenuates pathologic features of disease. J Clin Invest (2011) 1.11
alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury. J Neurotrauma (2009) 1.11
Blood-based diagnostics of traumatic brain injuries. Expert Rev Mol Diagn (2011) 1.10
Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator. J Neurotrauma (2012) 1.10
Neuro-glial and systemic mechanisms of pathological responses in rat models of primary blast overpressure compared to "composite" blast. Front Neurol (2012) 1.10
Glial neuronal ratio: a novel index for differentiating injury type in patients with severe traumatic brain injury. J Neurotrauma (2012) 1.09
Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system. Cancer Res (2006) 1.08
Role of ERK1/2 and p38 mitogen-activated protein kinases in the regulation of thrombospondin-1 by TGF-beta1 in rat proximal tubular cells and mouse fibroblasts. J Am Soc Nephrol (2005) 1.07
Serum biomarkers of MRI brain injury in neonatal hypoxic ischemic encephalopathy treated with whole-body hypothermia: a pilot study. Pediatr Crit Care Med (2013) 1.07
A structural model for the inhibition of calpain by calpastatin: crystal structures of the native domain VI of calpain and its complexes with calpastatin peptide and a small molecule inhibitor. J Mol Biol (2003) 1.07
Extensive degradation of myelin basic protein isoforms by calpain following traumatic brain injury. J Neurochem (2006) 1.07
Alteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: pluronic P85. Mol Pharm (2006) 1.05
GFAP out-performs S100β in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions. J Neurotrauma (2014) 1.05
Methamphetamine- and trauma-induced brain injuries: comparative cellular and molecular neurobiological substrates. Biol Psychiatry (2009) 1.04
Identifying sources and assessing potential risk of heavy metals in soils from direct exposure to children in a mine-impacted city, Changsha, China. J Environ Qual (2010) 1.03
Use of biomarkers for diagnosis and management of traumatic brain injury patients. Expert Opin Med Diagn (2008) 1.02
Serum brain biomarker level, neurocognitive performance, and self-reported symptom changes in soldiers repeatedly exposed to low-level blast: a breacher pilot study. J Neurotrauma (2013) 1.01
Increased expression and processing of caspase-12 after traumatic brain injury in rats. J Neurochem (2004) 1.01
Delayed increases in microvascular pathology after experimental traumatic brain injury are associated with prolonged inflammation, blood-brain barrier disruption, and progressive white matter damage. J Neurotrauma (2014) 1.00
Transcriptional activation of gene expression by pluronic block copolymers in stably and transiently transfected cells. Mol Ther (2005) 1.00
Sequential degradation of alphaII and betaII spectrin by calpain in glutamate or maitotoxin-stimulated cells. Biochemistry (2007) 0.98